Ovid Therapeutics Inc.

Ovid Therapeutics Inc.verified

OVID

Price:

$1.05

Market Cap:

$74.56M

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collabo...[Read more]

Industry

Biotechnology

IPO Date

2017-05-05

Stock Exchange

NASDAQ

Ticker

OVID

The Current Ratio as of November 2024 (TTM) for Ovid Therapeutics Inc. (OVID) is 5.66

According to Ovid Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.66. This represents a change of -27.91% compared to the average of 7.85 of the last 4 quarters.

Ovid Therapeutics Inc. (OVID) Historical Current Ratio (quarterly & annually)

How has OVID Current Ratio performed in the past?

The mean historical Current Ratio of Ovid Therapeutics Inc. over the last ten years is 15.68. The current 5.66 Current Ratio has changed 3.51% with respect to the historical average. Over the past ten years (40 quarters), OVID's Current Ratio was at its highest in in the December 2015 quarter at 30.44. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

15.68

Median

13.46

Minimum

3.39

Maximum

40.41

Ovid Therapeutics Inc. (OVID) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ovid Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 279.44%

Maximum Annual Current Ratio = 40.41

Minimum Annual Increase = -65.98%

Minimum Annual Current Ratio = 3.39

Quarterly (TTM)
Annual
YearCurrent RatioChange
20239.55-49.17%
202218.7945.99%
202112.87279.44%
20203.39-55.23%
20197.5851.38%
20185.01-65.98%
201714.714.80%
201614.04-53.88%
201530.44-24.69%

Ovid Therapeutics Inc. (OVID) Average Current Ratio

How has OVID Current Ratio performed in the past?

The current Current Ratio of Ovid Therapeutics Inc. (OVID) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

13.74

5-year avg

10.44

10-year avg

15.68

Ovid Therapeutics Inc. (OVID) Current Ratio vs. Peers

How is OVID’s Current Ratio compared to its peers?

Ovid Therapeutics Inc.’s Current Ratio is greater than CytomX Therapeutics, Inc. (1.04), greater than Spero Therapeutics, Inc. (2.68), less than Neoleukin Therapeutics, Inc. (15.33), less than Instil Bio, Inc. (12.90), less than NextCure, Inc. (9.07), greater than Assembly Biosciences, Inc. (2.36), less than Achilles Therapeutics plc (6.04), less than Nuvation Bio Inc. (9.57), less than Connect Biopharma Holdings Limited (12.04),

Build a custom stock screener for Ovid Therapeutics Inc. (OVID) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ovid Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ovid Therapeutics Inc. (OVID) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ovid Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Ovid Therapeutics Inc.'s Current Ratio?

How is the Current Ratio calculated for Ovid Therapeutics Inc. (OVID)?

What is the highest Current Ratio for Ovid Therapeutics Inc. (OVID)?

What is the 3-year average Current Ratio for Ovid Therapeutics Inc. (OVID)?

What is the 5-year average Current Ratio for Ovid Therapeutics Inc. (OVID)?

How does the current Current Ratio for Ovid Therapeutics Inc. (OVID) compare to its historical average?